Doppler assessment of hypoxic pulmonary vasoconstriction and susceptibility to high altitude pulmonary oedema

Vachiéry, J L; McDonagh, T; Moraine, J J; Berré, J; Naeije, R; Dargie, H; Peacock, A J
January 1995
Thorax;Jan1995, Vol. 50 Issue 1, p22
Academic Journal
journal article
No abstract available.


Related Articles

  • Susceptibility to high altitude pulmonary oedema: role of ACE and ET-1 polymorphisms. Charu, R.; Stobdan, T.; Ram, R. B.; Khan, A. P.; Qadar Pasha, M. A.; Norboo, T.; Afrin, F. // Thorax;Nov2006, Vol. 61 Issue 11, p1011 

    A letter to the editor discussing the role of angiotensin converting enzyme and endothelin-1 to the susceptibility to high altitude pulmonary oedema of the human body is presented.

  • Update on High-Altitude Pulmonary Edema: Pathogenesis, Prevention, and Treatment. Stream, Joshua O.; Grissom, Colin K. // Wilderness & Environmental Medicine;Winter2008, Vol. 19 Issue 4, p293 

    High-altitude pulmonary edema (HAPE) is a life-threatening noncardiogenic form of pulmonary edema (PE) that afflicts susceptible persons after rapid ascent to high altitude above 2500 m. Its pathogenesis is related to increased sympathetic tone, exaggerated hypoxic pulmonary vasoconstriction,...

  • LUNG ALERT........: Sildenafil and exercise capacity in hypoxic pulmonary hypertension. Mughal, M. M. // Thorax;Nov2004, Vol. 59 Issue 11, p999 

    The article presents information about a study, which examined the influence of oral sildenafil on pulmonary haemodynamics, and exercise tolerance during hypoxia induced pulmonary hypertension in healthy mountaineers and trekkers who were not susceptible to high altitude pulmonary edema. The...

  • High altitude-induced pulmonary oedema. Maggiorini, Marco // Cardiovascular Research;Oct2006, Vol. 72 Issue 1, p41 

    Abstract: Almost one mountain trekker or climber out of two develops several symptoms of high altitude illness after a rapid ascent (>300�m/day) to an altitude above 4000�m. Individual susceptibility is the most important determinant for the occurrence of high altitude pulmonary oedema...

  • PHOSPHODIESERTERASE 5 INHIBITORS (SILDENAFIL) TO ENHANCE ALTITUDE EXERCISE PERFORMANCE? Gotshall, Robert W. // Journal of Exercise Physiology Online;Jun2007, Vol. 10 Issue 3, p14 

    Exercise performance is reduced by both acute and chronic exposure to hypobaric hypoxia (altitude). Recently, phosphodiesterase (PDE5) 5 inhibitors have been shown to reduce hypoxic pulmonary vasoconstriction (HPV), and to improve altitude exercise performance. This review provides the...

  • Cytosolic phospholipase A(sub2) in hypoxic pulmonary vasoconstriction. Ichinose, Fumito; Ullrich, Roman; Sapirstein, Adam; Jones, Rosemary C.; Bonventre, Joseph V.; Serhan, Charles N.; Bloch, Kenneth D.; Zapol, Warren M. // Journal of Clinical Investigation;6/1/2002, Vol. 109 Issue 11, p1493 

    Assesses the role of cytosolic phospholipase A[sub2] in hypoxic pulmonary vasoconstriction (HPV). Measurement of the increase in left lung pulmonary vascular resistance; Effects of exogenous arachidonic acid on HPV; Pulmonary vascular response to angiotensin II.

  • Neurogenic pulmonary oedema. O'Leary, Ronan; McKinlay, Justin // Continuing Education in Anaesthesia, Critical Care & Pain;Jun2011, Vol. 11 Issue 3, p87 

    The article provides information on neurogenic pulmonary oedema (NPO), the most common form of hydrostatic pulmonary oedema (PO). An overview of PO physiology is presented, emphasizing the significance of transalveolar pressure in NPO development. Recommendations on managing NPO is offered,...

  • HYPOXIA, MECHANISMS AND LUNG VASCULATURE.  // Thorax;Dec2001 Supp, Vol. 56, piii34 

    This article presents various related to hypoxia and lung vasculature. The cause of altitude disease remain unclear, even more obscure is why some individuals perform better at altitude than others. The increased minute ventilation and alveolar ventilation, as demonstarted by the greater...

  • Inhibitors of hypoxic pulmonary vasoconstriction prevent high-altitude pulmonary edema in rats. Berg, John T.; Ramanathan, S.; Swenson, Erik R. // Wilderness & Environmental Medicine;Spring2004, Vol. 15 Issue 1, p32 

    Objective: Rapid ascent to high altitude causes hypoxic pulmonary vasoconstriction (HPV) and leads to high-altitude pulmonary edema (HAPE) in susceptible humans. Vasodilating agents lessen HAPE (as evidenced by radiographic and gas exchange measurements), but data establishing their...

  • Gender bender. Bellinson, Jerry; Olsson, Helen // Skiing;Feb98, Vol. 50 Issue 6, p30 

    Reports on the gender differences of the health impact of high altitudes. Men regarded as more susceptible to high altitude pulmonary edema (HAPE); Women's ability to better adapt to high altitude when it comes to body mass maintenance.


Read the Article


Sign out of this library

Other Topics